Identification of patients with autosomal dominant polycystic kidney disease at highest risk for end-stage renal disease
- PMID: 9335384
- DOI: 10.1681/ASN.V8101560
Identification of patients with autosomal dominant polycystic kidney disease at highest risk for end-stage renal disease
Abstract
To identify those potential factors that, early in the course of disease, mark a population of patients with autosomal dominant polycystic kidney disease (ADPKD) who have worse renal survival, survival analysis and risk ratio calculation for 1215 ADPKD patients were performed. Survival times were calculated as time to dialysis, transplantation, or death. Risk ratios were calculated using the Cox proportional hazards model. Three hundred eighty-eight patients entered end-stage renal disease and 205 patients died. ADPKD2 subjects had longer renal survival than ADPKD1 subjects (median survival, 68 versus 53 yr; P < 0.0005; risk ratio, 2.5). Women had significantly better renal survival than men (56 versus 52 yr; P < 0.0001; risk ratio, 1.6). Subjects who were diagnosed before age 30 and those who developed hypertension before age 35 had worse renal survival than those subjects who were diagnosed after age 30 or those who remained normotensive after age 35, respectively (age of diagnosis: 49 versus 59 yr; P < 0.0001; risk ratio, 3.2; hypertension: 51 versus 65 yr; P < 0.0001; risk ratio, 4.4). Similarly, those who had an episode of gross hematuria before age 30 had a worse renal outcome than those who did not (49 versus 59 yr; P < 0.0001; risk ratio, 2.6). We have also calculated risk ratios for a combined model. When therapeutic interventions become available for this disease, these populations with high risk ratios should be considered for such interventions.
Similar articles
-
Factors affecting the progression of renal disease in autosomal-dominant polycystic kidney disease.Kidney Int. 1992 May;41(5):1311-9. doi: 10.1038/ki.1992.195. Kidney Int. 1992. PMID: 1614046
-
The effect of uninephrectomy on progression of renal failure in autosomal dominant polycystic kidney disease.J Am Soc Nephrol. 1992 Nov;3(5):1119-23. doi: 10.1681/ASN.V351119. J Am Soc Nephrol. 1992. PMID: 1482752
-
Do metabolic derangements in end-stage polycystic kidney disease differ versus other primary kidney diseases?Nephrology (Carlton). 2018 Jan;23(1):31-36. doi: 10.1111/nep.12927. Nephrology (Carlton). 2018. PMID: 27653449
-
Clinical problems in hemodialysis patients with autosomal dominant polycystic kidney disease.Semin Dial. 2018 May;31(3):268-277. doi: 10.1111/sdi.12696. Epub 2018 Apr 17. Semin Dial. 2018. PMID: 29664556 Review.
-
Autosomal Dominant Polycystic Kidney Disease.Prim Care. 2020 Dec;47(4):673-689. doi: 10.1016/j.pop.2020.08.010. Prim Care. 2020. PMID: 33121636 Review.
Cited by
-
Molecular pathways and therapies in autosomal-dominant polycystic kidney disease.Physiology (Bethesda). 2015 May;30(3):195-207. doi: 10.1152/physiol.00032.2014. Physiology (Bethesda). 2015. PMID: 25933820 Free PMC article. Review.
-
Predicting autosomal dominant polycystic kidney disease progression: review of promising Serum and urine biomarkers.Front Pediatr. 2023 Nov 10;11:1274435. doi: 10.3389/fped.2023.1274435. eCollection 2023. Front Pediatr. 2023. PMID: 38027263 Free PMC article. Review.
-
A novel heterozygous PKD1 variant causing alternative splicing in a Chinese family with autosomal dominant polycystic kidney disease.Mol Genet Genomic Med. 2023 Aug;11(8):e2217. doi: 10.1002/mgg3.2217. Epub 2023 Jun 5. Mol Genet Genomic Med. 2023. PMID: 37272738 Free PMC article.
-
Cilia-enriched oxysterol 7β,27-DHC is required for polycystin ion channel activation.Nat Commun. 2024 Jul 31;15(1):6468. doi: 10.1038/s41467-024-50318-9. Nat Commun. 2024. PMID: 39085216 Free PMC article.
-
Cardiometabolic comorbidities in autosomal dominant polycystic kidney disease: a 16-year retrospective cohort study.BMC Nephrol. 2023 Nov 9;24(1):333. doi: 10.1186/s12882-023-03382-0. BMC Nephrol. 2023. PMID: 37946153 Free PMC article.
Publication types
MeSH terms
Grants and funding
LinkOut - more resources
Full Text Sources
Medical